Insider Purchases: Inside the Buy
Tag: Stock Analysis 2026
☕ Black Rock Coffee Bar (BRCB): The Hypergrowth Coffee Chain Wall Street May Have Oversold
Black Rock Coffee Bar (NASDAQ: BRCB) may be one of the market’s more fascinating small-cap growth stories hiding beneath a brutal selloff. With insider buying accelerating, revenue climbing nearly 24%, and profitability improving, investors are beginning to wonder whether Wall Street overshot the downside.
🏗️ AECOM (ACM): The $26 Billion Backlog Infrastructure Giant Trading at 12x Earnings
AECOM (NYSE: ACM) may be one of the most misunderstood infrastructure stocks in the market. With a record $26.2 billion backlog, insider buying from top executives, and a surprisingly cheap valuation, this engineering and consulting powerhouse could be quietly laying the foundation for substantial long-term upside.
🚐 Patrick Industries Stock: Insider Buying, RV Rebound, and the Weekend Economy Play
Patrick Industries (PATK) is flashing a rare mix of insider conviction, institutional crowding, reasonable valuation, and cyclical risk. The setup looks promising — but patience may beat chasing.
🏛️ S&P Global (SPGI): The Toll Booth of Capitalism Gets a “Sale” Sign
S&P Global isn’t just a company—it’s the infrastructure of modern finance. With valuation down ~30% and insiders buying, is this a rare opportunity to own a wide-moat compounder at a discount?
🩺 GE HealthCare (GEHC): Insider Buying, AI Growth & a $21B Backlog Opportunity
GE HealthCare (GEHC) is quietly shaping up as a high-visibility MedTech play, combining insider buying, a $21.8B backlog, and AI-driven diagnostics. With valuation still reasonable and institutional ownership near record levels, this could be a compelling long-term compounder—if you’re patient on entry.
🍫 Simply Good Foods (SMPL): Low Carb, Low Price, or Just Low Expectations?
Simply Good Foods (SMPL) is down sharply, trading at bargain-style valuation levels while insiders keep buying. Is this protein-packed stock a turnaround snack—or a melting low-carb ice cube?
Badger Meter (BMI) Stock Analysis 2026: Insider Buys After 24% Crash 💧📉
Badger Meter just took a 24% hit—but the CEO is buying the dip. With strong long-term water infrastructure trends and improved valuation, is BMI a hidden opportunity or just treading water?
CORT Stock 2026: FDA Rejection, Insider Buying… and a Brewing Short Squeeze?
Corcept Therapeutics just got hit with an FDA rejection—but insiders are buying millions and short interest is surging. With a profitable base business and major 2026 catalysts ahead, CORT may be one of the most explosive “binary bets” in biotech today.
TTD Stock Analysis 2026: Jeff Green’s $148M Bet — Is The Trade Desk the Ultimate “Buy the Dip” Play?
The Trade Desk just got the loudest kind of bullish signal: the founder-CEO bought $148M of his own stock after an 80%+ drawdown. Institutions are stacked, shorts are circling, and valuation has finally cooled from “bubble” to “business.” The question now: is TTD a generational dip… or a beautiful trap?
NOW Stock Analysis 2026: Bill McDermott’s $3M “Strong Buy” Signal — Is ServiceNow the AI Control Tower?
ServiceNow (NOW) is fighting a valuation reset with AI-powered fundamentals. CEO Bill McDermott just made a rare $3M insider buy — a signal worth decoding.